![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0057.png)
57
53. Tong GM, Rude RK. Magnesium
deficiency in critical illness. J Intensive Care
Med 2005;20:3-17.
54. Cholst IN, Steinberg SF, Tropper PJ, Fox
HE, Segre GV, Bilezikian JP. The influence of
hypermagnesemia on serum calcium and
parathyroid hormone levels in human subjects.
N Engl J Med 1984;310:1221-5.
55. Porter RH, Cox BG, Heaney D, Hostetter
TH, Stinebaugh BJ, Suki WN. Treatment of
hypoparathyroid patients with chlorthalidone.
N Engl J Med 1978;298:577-81.
56. Rubin MR, Sliney J Jr., McMahon DJ,
Silverberg SJ, Bilezikian JP. Therapy of
hypoparathyroidism with intact parathyroid
hormone. Osteoporos Int. [Clinical Trial
Research Support, N.I.H., Extramural Research
Support, Non-U.S. Gov't]. 2010;21:1927-34.
57. Winer KK, Sinaii N, Reynolds J, Peterson
D, Dowdy K, Cutler GB Jr. Long-term
treatment of 12 children with chronic
hypoparathyroidism: a randomized trial
comparing synthetic human parathyroid
hormone 1-34 versus calcitriol and calcium. J
Clin Endocrinol Metab 2010;95:2680-8.
58. Sikjaer T, Rejnmark L, Rolighed L,
Heickendorff L, Mosekilde L. The effect of
adding PTH(1-84) to conventional treatment of
hypoparathyroidism: a randomized, placebo-